vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Inspirato Inc (ISPO). Click either name above to swap in a different company.
Inspirato Inc is the larger business by last-quarter revenue ($55.5M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). IRONWOOD PHARMACEUTICALS INC runs the higher net margin — -4.8% vs -8.1%, a 3.4% gap on every dollar of revenue. On growth, Inspirato Inc posted the faster year-over-year revenue change (-19.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-3.0M). Over the past eight quarters, Inspirato Inc's revenue compounded faster (-11.4% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Inspirato Inc is a luxury travel and hospitality subscription service provider catering primarily to high-net-worth consumers across North America. It offers curated premium villa rentals, exclusive resort access, customized trip planning, and corporate travel incentive solutions for enterprise clients.
IRWD vs ISPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $55.5M |
| Net Profit | $-2.3M | $-4.5M |
| Gross Margin | — | 31.4% |
| Operating Margin | 14.3% | -8.0% |
| Net Margin | -4.8% | -8.1% |
| Revenue YoY | -47.3% | -19.6% |
| Net Profit YoY | -200.9% | -204.4% |
| EPS (diluted) | $0.01 | $-0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | — | ||
| Q3 25 | $122.1M | $55.5M | ||
| Q2 25 | $85.2M | $63.1M | ||
| Q1 25 | $41.1M | $65.9M | ||
| Q4 24 | $90.5M | $63.1M | ||
| Q3 24 | $91.6M | $69.1M | ||
| Q2 24 | $94.4M | $67.4M | ||
| Q1 24 | $74.9M | $80.2M |
| Q4 25 | $-2.3M | — | ||
| Q3 25 | $40.1M | $-4.5M | ||
| Q2 25 | $23.6M | $-5.3M | ||
| Q1 25 | $-37.4M | $1.6M | ||
| Q4 24 | $2.3M | $-2.3M | ||
| Q3 24 | $3.6M | $4.3M | ||
| Q2 24 | $-860.0K | $-8.7M | ||
| Q1 24 | $-4.2M | $1.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 31.4% | ||
| Q2 25 | — | 27.5% | ||
| Q1 25 | — | 38.8% | ||
| Q4 24 | — | 34.7% | ||
| Q3 24 | — | 71.5% | ||
| Q2 24 | — | 24.0% | ||
| Q1 24 | — | 39.5% |
| Q4 25 | 14.3% | — | ||
| Q3 25 | 61.8% | -8.0% | ||
| Q2 25 | 53.2% | -8.3% | ||
| Q1 25 | -70.7% | 2.5% | ||
| Q4 24 | 34.8% | -3.2% | ||
| Q3 24 | 28.0% | 9.8% | ||
| Q2 24 | 26.5% | -22.8% | ||
| Q1 24 | 14.7% | 3.0% |
| Q4 25 | -4.8% | — | ||
| Q3 25 | 32.8% | -8.1% | ||
| Q2 25 | 27.7% | -8.4% | ||
| Q1 25 | -90.9% | 2.5% | ||
| Q4 24 | 2.5% | -3.6% | ||
| Q3 24 | 4.0% | 6.3% | ||
| Q2 24 | -0.9% | -12.9% | ||
| Q1 24 | -5.6% | 1.6% |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.23 | $-0.36 | ||
| Q2 25 | $0.14 | $-0.42 | ||
| Q1 25 | $-0.23 | $0.12 | ||
| Q4 24 | $0.03 | $0.98 | ||
| Q3 24 | $0.02 | $0.62 | ||
| Q2 24 | $-0.01 | $-2.33 | ||
| Q1 24 | $-0.03 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $13.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $-134.0M |
| Total Assets | $396.9M | $228.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | $13.7M | ||
| Q2 25 | $92.9M | $16.7M | ||
| Q1 25 | $108.5M | $16.4M | ||
| Q4 24 | $88.6M | $21.8M | ||
| Q3 24 | $88.2M | $13.5M | ||
| Q2 24 | $105.5M | $18.8M | ||
| Q1 24 | $121.5M | $22.6M |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | — | ||
| Q3 25 | $-264.2M | $-134.0M | ||
| Q2 25 | $-308.2M | $-129.7M | ||
| Q1 25 | $-334.1M | $-125.2M | ||
| Q4 24 | $-301.3M | $-129.9M | ||
| Q3 24 | $-311.3M | $-134.6M | ||
| Q2 24 | $-321.7M | $-35.2M | ||
| Q1 24 | $-330.5M | $-27.5M |
| Q4 25 | $396.9M | — | ||
| Q3 25 | $396.1M | $228.3M | ||
| Q2 25 | $342.9M | $252.6M | ||
| Q1 25 | $327.2M | $270.1M | ||
| Q4 24 | $350.9M | $273.9M | ||
| Q3 24 | $389.5M | $273.3M | ||
| Q2 24 | $395.6M | $301.7M | ||
| Q1 24 | $438.8M | $313.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $-2.2M |
| Free Cash FlowOCF − Capex | $74.6M | $-3.0M |
| FCF MarginFCF / Revenue | 156.3% | -5.4% |
| Capex IntensityCapex / Revenue | 0.0% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $-31.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | $-2.2M | ||
| Q2 25 | $-15.1M | $1.1M | ||
| Q1 25 | $20.0M | $-6.6M | ||
| Q4 24 | $15.2M | $-15.8M | ||
| Q3 24 | $9.9M | $-13.7M | ||
| Q2 24 | $33.5M | $-1.8M | ||
| Q1 24 | $45.0M | $-7.2M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | $-3.0M | ||
| Q2 25 | $-15.1M | $468.0K | ||
| Q1 25 | $19.9M | $-7.5M | ||
| Q4 24 | — | $-21.2M | ||
| Q3 24 | $9.9M | $-14.8M | ||
| Q2 24 | $33.4M | $-3.7M | ||
| Q1 24 | $44.9M | $-8.5M |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | -5.4% | ||
| Q2 25 | -17.7% | 0.7% | ||
| Q1 25 | 48.4% | -11.4% | ||
| Q4 24 | — | -33.7% | ||
| Q3 24 | 10.8% | -21.5% | ||
| Q2 24 | 35.4% | -5.5% | ||
| Q1 24 | 60.0% | -10.6% |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 0.0% | 1.0% | ||
| Q1 25 | 0.1% | 1.3% | ||
| Q4 24 | 0.0% | 8.7% | ||
| Q3 24 | 0.0% | 1.6% | ||
| Q2 24 | 0.1% | 2.8% | ||
| Q1 24 | 0.1% | 1.6% |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | -4.09× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | -3.16× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -5.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
ISPO
| Residence And Hotel Travel | $25.9M | 47% |
| Subscription | $19.4M | 35% |
| Experiences And Bespoke Travel | $8.0M | 14% |
| Rewards And Other Revenue | $2.3M | 4% |
